These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36935789)

  • 21. Intravitreal Dexamethasone Implant for Treatment of Sarcoidosis-Related Uveitis.
    Kim M; Kim SA; Park W; Kim RY; Park YH
    Adv Ther; 2019 Aug; 36(8):2137-2146. PubMed ID: 31140122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single Dexamethasone Intravitreal Implant in the Treatment of Noninfectious Uveitis.
    Frère A; Caspers L; Makhoul D; Judice L; Postelmans L; Janssens X; Lefebvre P; Mélot C; Willermain F
    J Ocul Pharmacol Ther; 2017 May; 33(4):290-297. PubMed ID: 28448238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of best corrected visual acuity and central macular thickness after intravitreal dexamethasone implant injections in patients with Irvine-Gass syndrome: A retrospective study of six cases.
    Keilani C; Halalchi A; Wakpi Djeugue D; Regis A; Abada S
    Therapie; 2016 Oct; 71(5):457-465. PubMed ID: 27203164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravitreal dexamethasone implant results in the treatment of non-infectious uveitis.
    Dikmen NT; Vural ET; Yenerel NM; Dikkaya F; Elibol ES; Kockar A
    North Clin Istanb; 2022; 9(6):638-645. PubMed ID: 36685630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravitreal dexamethasone implant for noninfectious uveitis in Chinese patients.
    Zeng S; Yang L; Bai F; Liu T; Liu X
    Int Ophthalmol; 2022 Jul; 42(7):2063-2069. PubMed ID: 34984627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dexamethasone Intravitreal Implant Injection in Eyes with Comorbid Hypotony.
    Kong X; Psaras C; Stewart JM
    Ophthalmol Retina; 2019 Nov; 3(11):993-997. PubMed ID: 31371197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
    Haller JA; Bandello F; Belfort R; Blumenkranz MS; Gillies M; Heier J; Loewenstein A; Yoon YH; Jacques ML; Jiao J; Li XY; Whitcup SM;
    Ophthalmology; 2010 Jun; 117(6):1134-1146.e3. PubMed ID: 20417567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study.
    Georgalas L; Tservakis I; Kiskira EE; Petrou P; Papaconstantinou D; Kanakis M
    Cutan Ocul Toxicol; 2019 Dec; 38(4):330-337. PubMed ID: 31060385
    [No Abstract]   [Full Text] [Related]  

  • 29. Dexamethasone intravitreal implant (Ozurdex) in diabetic macular edema: real-world data versus clinical trials outcomes.
    Neves P; Ornelas M; Matias I; Rodrigues J; Santos M; Dutra-Medeiros M; Martins D
    Int J Ophthalmol; 2021; 14(10):1571-1580. PubMed ID: 34667735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant.
    Myung JS; Aaker GD; Kiss S
    Clin Ophthalmol; 2010 Dec; 4():1423-6. PubMed ID: 21188153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravitreal Dexamethasone Implant as an Adjunct Weapon for Severe and Refractory Uveitis in Behçet's Disease.
    Fabiani C; Emmi G; Lopalco G; Vannozzi L; Bacherini D; Guerriero S; Franceschini R; Frediani B; Iannone F; Marco Tosi G; Rigante D; Cantarini L
    Isr Med Assoc J; 2017 Jul; 19(7):415-419. PubMed ID: 28786255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phacoemulsification cataract extraction and intraocular lens implantation in patients with uveitis.
    Kawaguchi T; Mochizuki M; Miyata K; Miyata N
    J Cataract Refract Surg; 2007 Feb; 33(2):305-9. PubMed ID: 17276275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravitreal injection versus systematic treatment in patients with uveitis undergoing cataract surgery: a systematic review and meta-analysis.
    Hsieh YH; Jhou HJ; Chen PH; Hwang YS
    Graefes Arch Clin Exp Ophthalmol; 2023 Mar; 261(3):809-820. PubMed ID: 36271933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcomes of cataract surgery in children with uveitis.
    Yangzes S; Seth NG; Singh R; Gupta PC; Jinagal J; Pandav SS; Gupta V; Gupta A; Ram J
    Indian J Ophthalmol; 2019 Apr; 67(4):490-495. PubMed ID: 30900580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
    Mehta H; Hennings C; Gillies MC; Nguyen V; Campain A; Fraser-Bell S
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011599. PubMed ID: 29669176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.
    Haller JA; Bandello F; Belfort R; Blumenkranz MS; Gillies M; Heier J; Loewenstein A; Yoon YH; Jiao J; Li XY; Whitcup SM; ; Li J
    Ophthalmology; 2011 Dec; 118(12):2453-60. PubMed ID: 21764136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PROSPECTIVE EVALUATION OF A SUSTAINED-RELEASE DEXAMETHASONE INTRAVITREAL IMPLANT FOR CYSTOID MACULAR EDEMA IN QUIESCENT UVEITIS.
    Khurana RN; Bansal AS; Chang LK; Palmer JD; Wu C; Wieland MR
    Retina; 2017 Sep; 37(9):1692-1699. PubMed ID: 27893624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of intravitreal dexamethasone implant 0.7 mg (Ozurdex®) in non-infectious posterior uveitis.
    Yap YC; Papathomas T; Kamal A
    Int J Ophthalmol; 2015; 8(4):835-8. PubMed ID: 26309888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term evaluation of dexamethasone intravitreal implant in vitrectomized and non-vitrectomized eyes with macular edema secondary to non-infectious uveitis.
    Pelegrín L; de la Maza MS; Molins B; Ríos J; Adán A
    Eye (Lond); 2015 Jul; 29(7):943-50. PubMed ID: 25998942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ozurdex (dexamethasone intravitreal implant) for the treatment of intermediate, posterior, and panuveitis: a systematic review of the current evidence.
    Saincher SS; Gottlieb C
    J Ophthalmic Inflamm Infect; 2020 Jan; 10(1):1. PubMed ID: 31925591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.